Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain

NCT00236093 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cephalon